Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/31595
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorNUNES, Valeria Sutti
dc.contributor.authorCAZITA, Patricia Miralda
dc.contributor.authorCATANOZI, Sergio
dc.contributor.authorNAKANDAKARE, Edna Regina
dc.contributor.authorQUINTAO, Eder Carlos Rocha
dc.date.accessioned2019-05-30T13:19:51Z
dc.date.available2019-05-30T13:19:51Z
dc.date.issued2019
dc.identifier.citationJOURNAL OF BIOENERGETICS AND BIOMEMBRANES, v.51, n.2, p.131-136, 2019
dc.identifier.issn0145-479X
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/31595
dc.description.abstractPhytosterol metabolism is unknown in the hypercholesterolemia of genetic origin. We investigated the metabolism of phytosterols in a cholesterol-free, phytosterol-containing standard diet in hypercholesterolemic mice knockouts for low density lipoprotein receptor (LDLR) and apolipoprotein E (apoE) mice compared to wild-type mice (controls). Phytosterols were measured in mice tissues by GCMS. ApoE-KO mice absorbed less phytosterols than LDLR-KO and the latter absorbed less phytosterols than control mice, because the intestinal campesterol content was low in both KO mice, and sitosterol was low in the intestine in apoE-KO mice as compared to LDLR-KO mice. Although the diet contained nine times more sitosterol than campesterol, the concentration of sitosterol was lower than that of campesterol in plasma in LDLR-KO, and in the liver in controls and in LDLR-KO, but only in apoE-KO. On the other hand, in the intestine sitosterol was higher than campesterol in controls, and in LDLR-KO but with a tendency only in apoE-KO. Because of the high dietary supply of sitosterol, sitosterol was better taken up by the intestine than campesterol, but the amount of sitosterol was lower than that of campesterol in the liver, while in the whole body the amounts of these phytosterols do not differ from each other. Therefore, via intestinal lymph less sitosterol than campesterol was transferred to the body. However, as compared to controls, in apoE-KO mice, but not in LDLR-KO mice, the increase in campesterol and sitosterol in plasma and in the whole body indicating that apoE-KO mice have a marked defect in the elimination of both phytosterols from the body.eng
dc.description.sponsorshipSao Paulo Research Foundation (FAPESP), Sao Paulo, Brazil [2015-17566-2]
dc.language.isoeng
dc.publisherSPRINGER/PLENUM PUBLISHERSeng
dc.relation.ispartofJournal of Bioenergetics and Biomembranes
dc.rightsrestrictedAccesseng
dc.subjectKnockout miceeng
dc.subjectPhytosterolseng
dc.subjectHypercholesterolemiaeng
dc.subjectApo E knockout miceeng
dc.subjectLow density lipoprotein receptoreng
dc.subject.otherdensity-lipoprotein receptoreng
dc.subject.othernon-cholesterol sterolseng
dc.subject.otherplant sterolseng
dc.subject.otherintestinal-absorptioneng
dc.subject.othersurrogate markerseng
dc.subject.otherserum-cholesteroleng
dc.subject.otherlivereng
dc.subject.otherhypercholesterolemiaeng
dc.subject.otherpopulationeng
dc.subject.othermetabolismeng
dc.titlePhytosterol containing diet increases plasma and whole body concentration of phytosterols in apoE-KO but not in LDLR-KO miceeng
dc.typearticleeng
dc.rights.holderCopyright SPRINGER/PLENUM PUBLISHERSeng
dc.identifier.doi10.1007/s10863-019-09786-8
dc.identifier.pmid30739226
dc.subject.wosBiophysicseng
dc.subject.wosCell Biologyeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
hcfmusp.description.beginpage131
hcfmusp.description.endpage136
hcfmusp.description.issue2
hcfmusp.description.volume51
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000463575300004
hcfmusp.origem.id2-s2.0-85061332441
hcfmusp.publisher.cityNEW YORKeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceAndersson SW, 2004, EUR J CLIN NUTR, V58, P1378, DOI 10.1038/sj.ejcn.1601980eng
hcfmusp.relation.referenceBaila-Rueda L, 2016, ATHEROSCLEROSIS, V246, P202, DOI 10.1016/j.atherosclerosis.2016.01.005eng
hcfmusp.relation.referenceBHATTACHARYYA AK, 1981, AM J PHYSIOL, V240, pG50eng
hcfmusp.relation.referenceBombo RPA, 2013, ATHEROSCLEROSIS, V231, P442, DOI 10.1016/j.atherosclerosis.2013.10.015eng
hcfmusp.relation.referenceCalandra S, 2017, CURR OPIN LIPIDOL, V28, P267, DOI 10.1097/MOL.0000000000000414eng
hcfmusp.relation.referenceGRUNDY SM, 1969, J LIPID RES, V10, P304eng
hcfmusp.relation.referenceGylling H, 2005, ANN CLIN BIOCHEM, V42, P254, DOI 10.1258/0004563054255605eng
hcfmusp.relation.referenceGylling H, 2014, ATHEROSCLEROSIS, V232, P346, DOI 10.1016/j.atherosclerosis.2013.11.043eng
hcfmusp.relation.referenceHamada T, 2006, LIPIDS, V41, P551, DOI 10.1007/s11745-006-5004-yeng
hcfmusp.relation.referenceKohler J, 2017, BRIT J PHARMACOL, V174, P1281, DOI 10.1111/bph.13764eng
hcfmusp.relation.referenceLupattelli G, 2012, NUTR METAB CARDIOVAS, V22, P231, DOI 10.1016/j.numecd.2010.05.010eng
hcfmusp.relation.referenceMartins CM, 2013, NUTRITION, V29, P865, DOI 10.1016/j.nut.2012.12.017eng
hcfmusp.relation.referenceMatthan NR, 2009, J LIPID RES, V50, P1927, DOI 10.1194/jlr.P900039-JLR200eng
hcfmusp.relation.referenceMiettinen TA, 2011, NUTR METAB CARDIOVAS, V21, P765, DOI 10.1016/j.numecd.2011.05.005eng
hcfmusp.relation.referenceMiettinen TA, 2006, GASTROENTEROLOGY, V130, P542, DOI 10.1053/j.gastro.2005.10.022eng
hcfmusp.relation.referenceMoghadasian MH, 2001, METABOLISM, V50, P708, DOI 10.1053/meta.2001.23303eng
hcfmusp.relation.referenceMoruisi KG, 2006, J AM COLL NUTR, V25, P41, DOI 10.1080/07315724.2006.10719513eng
hcfmusp.relation.referenceMymin D, 2018, ATHEROSCLEROSIS, V269, P122, DOI 10.1016/j.atherosclerosis.2017.12.024eng
hcfmusp.relation.referenceNational Research Council, 2011, GUIDE CARE USE LAB A, DOI [10. 17226/12910, DOI 10.17226/12910, 10.17226/12910]eng
hcfmusp.relation.referenceNunes VS, 2011, CLIN CHIM ACTA, V412, P176, DOI 10.1016/j.cca.2010.09.039eng
hcfmusp.relation.referenceNunes VS, 2018, J BIOENERG BIOMEMBR, V50, P283, DOI 10.1007/s10863-018-9757-9eng
hcfmusp.relation.referenceOoi EMM, 2010, J LIPID RES, V51, P2413, DOI 10.1194/jlr.M004705eng
hcfmusp.relation.referenceOSONO Y, 1995, J CLIN INVEST, V95, P1124, DOI 10.1172/JCI117760eng
hcfmusp.relation.referencePlat J, 2008, METABOLISM, V57, P1241, DOI 10.1016/j.metabol.2008.04.018eng
hcfmusp.relation.referenceRysz J, 2017, CURR PHARM DESIGN, V23, P2488, DOI 10.2174/1381612823666170316112344eng
hcfmusp.relation.referenceSAMUEL P, 1983, J LIPID RES, V24, P265eng
hcfmusp.relation.referenceSimonen P, 2008, ATHEROSCLEROSIS, V197, P883, DOI 10.1016/j.atherosclerosis.2007.08.003eng
hcfmusp.relation.referenceSioen I, 2011, BRIT J NUTR, V105, P960, DOI 10.1017/S0007114510004587eng
hcfmusp.relation.referenceStellaard F, 2017, J STEROID BIOCHEM, V169, P111, DOI 10.1016/j.jsbmb.2016.03.030eng
hcfmusp.relation.referenceTang WQ, 2009, J LIPID RES, V50, P293, DOI 10.1194/jlr.M800439-JLR200eng
hcfmusp.relation.referencevon Bergmann K, 2005, AM J CARDIOL, V96, p10D, DOI 10.1016/j.amjcard.2005.03.014eng
hcfmusp.relation.referenceWang J, 2015, J LIPID RES, V56, P319, DOI 10.1194/jlr.M054544eng
hcfmusp.relation.referenceWeingartner O, 2015, J AOAC INT, V98, P742, DOI 10.5740/jaoacint.SGEWeingartnereng
hcfmusp.relation.referenceWoollett LA, 1995, P NATL ACAD SCI USA, V92, P12500, DOI 10.1073/pnas.92.26.12500eng
dc.description.indexMEDLINEeng
dc.identifier.eissn1573-6881
hcfmusp.citation.scopus5-
hcfmusp.scopus.lastupdate2024-03-29-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCM
Departamento de Clínica Médica - FM/MCM

Artigos e Materiais de Revistas Científicas - LIM/10
LIM/10 - Laboratório de Lípides


Files in This Item:
File Description SizeFormat 
art_NUNES_Phytosterol_containing_diet_increases_plasma_and_whole_body_2019.PDF
  Restricted Access
publishedVersion (English)412.97 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.